GlassScriptPhysician profile
Mary Cummins
NPI 1043296817
$2,873.21
in general payments reported to CMS, 2019-2025
20 companies · $147 in 2025
The $147 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $90.09 · 2022: $755 · 2023: $770 · 2024: $1,110 · 2025: $147.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,928.73 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $452.71 | 2021-2024 | |
| Janssen Biotech, INC. | $348.89 | 2021-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $347.90 | 2021-2025 | |
| Abbvie INC. | $286.01 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $252.01 | 2023-2024 | Odomzo, Blu-U, Winlevi |
| E.R. Squibb & Sons, L.L.C. | $215.96 | 2022-2024 | Sotyktu |
| Incyte Corporation | $201.97 | 2022-2024 | Opzelura |
| Lilly USA, LLC | $162.99 | 2022-2024 | Olumiant, Taltz |
| Pfizer INC. | $90.14 | 2022-2024 | |
| Leo Pharma INC. | $88.82 | 2022-2025 | Adbry, Spevigo |
| Galderma Laboratories, L.P. | $85.14 | 2022-2024 | Aklief |
| Regeneron Healthcare Solutions, INC. | $81.93 | 2023-2024 | Dupixent |
| Amgen INC. | $73.78 | 2022-2024 | Otezla |
| Ucb, INC. | $52.46 | 2024 | Bimzelx |
| Smith+Nephew, INC. | $49.65 | 2024 | Grafix, Stravix |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $21.06 | 2022 | |
| Arcutis Biotherapeutics, INC. | $19.56 | 2024 | Zoryve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.85 | 2023 | Spevigo |
| Sebela Pharmaceuticals INC. | $12.85 | 2022 | |
| Dermavant Sciences, INC. | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Cummins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.